Tiziana Life Sciences Ltd (TLSA)

02:30 AM

TLSA Begins Enrollment for Phase 2 Alzheimer's Clinical Trial - GuruFocus

02:30 AM

02:10 AM

Tiziana Life Sciences to Dose First Patient in Phase 2 Alzheimer’s Trial - Stock Titan

02:10 AM

10:27 AM

Tiziana Life Sciences to begin patient dosing in Phase 2 Alzheimer’s trial next week - Proactive financial news

10:27 AM

Dec 11, 2025

Is Tiziana Life Sciences Ltd a good long term investmentLow Beta Stocks & Make Confident Moves With Forecasting Models - earlytimes.in

Dec 11, 2025

Dec 09, 2025

Tiziana Life Sciences Shares Drop After Company Unveils Plan to Spin Out IL-6 Program - MSN

Dec 09, 2025

Dec 05, 2025

Will Tiziana Life Sciences Ltd stock deliver shareholder valueInsider Buying & Daily Stock Trend Watchlist - Newser

Dec 05, 2025

Dec 04, 2025

How Tiziana Life Sciences Ltd stock reacts to job market data2025 Dividend Review & Stepwise Trade Execution Plans - Newser

Dec 04, 2025

Dec 04, 2025

Is Tiziana Life Sciences Ltd stock near bottom after declineJuly 2025 Selloffs & Precise Swing Trade Alerts - Newser

Dec 04, 2025

Dec 04, 2025

Will Tiziana Life Sciences Ltd stock attract ESG investorsWeekly Stock Recap & Low Risk Entry Point Guides - Newser

Dec 04, 2025

Dec 03, 2025

Tiziana Life Sciences Ltd (TLSA) is looking forward to a strong quarter - setenews.com

Dec 03, 2025

Dec 03, 2025

Is KN Agri Resources Limited Stock a Safe Long Term Investment Data Breakdown - earlytimes.in

Dec 03, 2025

Dec 03, 2025

Small cap wrap: Tiziana Life Sciences, Gunnison Copper, Blockmate Ventures, Century Lithium… - Proactive financial news

Dec 03, 2025

Dec 03, 2025

Is Tiziana Life Sciences Ltd stock undervalued vs historical averagesTrade Exit Report & Weekly Stock Breakout Alerts - Newser

Dec 03, 2025

Dec 02, 2025

Tiziana Life Sciences to Set Up a Publicly Listed Immunology-Focused Spinout Company, Centered on the IL-6 Market - marketscreener.com

Dec 02, 2025

Dec 02, 2025

Tiziana Life Sciences stock falls after announcing IL-6 asset spinout By Investing.com - Investing.com Nigeria

Dec 02, 2025

Dec 02, 2025

Tiziana Life Sciences stock falls after announcing IL-6 asset spinout - Investing.com Nigeria

Dec 02, 2025

Dec 02, 2025

Tiziana Life Sciences plans spinout of IL-6 antibody program - Proactive financial news

Dec 02, 2025

Dec 02, 2025

Tiziana Life Sciences (TLSA) Plans Spinout to Develop Anti-IL-6 Antibody - GuruFocus

Dec 02, 2025

Dec 02, 2025

Tiziana Life Sciences Plans to Spin Off IL-6 Antibody Asset Into New Publicly Listed Company - marketscreener.com

Dec 02, 2025

Dec 02, 2025

Tiziana Life Sciences Plans to Spin Out Asset as Separate Company - marketscreener.com

Dec 02, 2025

Dec 02, 2025

Tiziana Life Sciences Plans to Spinout IL-6 Asset into Separate Listed Company - The Manila Times

Dec 02, 2025

Dec 02, 2025

Tiziana Life Sciences (Nasdaq: TLSA) to spin out IL-6 asset into new listed company - Stock Titan

Dec 02, 2025

Dec 01, 2025

Tiziana Life Sciences Ltd (TLSA) -5.03% in After-hours: What’s Driving the Move? - Stocks Telegraph

Dec 01, 2025

Nov 28, 2025

Take Profit: Why Tiziana Life Sciences Ltd stock appeals to dividend seekersQuarterly Profit Summary & AI Based Trade Execution Alerts - moha.gov.vn

Nov 28, 2025

Nov 26, 2025

Ready to Jump After Recent Trade: Tiziana Life Sciences Ltd (TLSA) - Setenews

Nov 26, 2025

Nov 25, 2025

Tiziana Life Sciences Ltd (TLSA) -5.3% in After-hours: Amid Routine Trading Conditions - Stocks Telegraph

Nov 25, 2025

Nov 25, 2025

Small cap wrap: Tiziana Life Sciences, Pinnacle Silver & Gold, Rainbow Rare Earths... - Proactive Investors

Nov 25, 2025

Nov 25, 2025

Phase 2 Trial of Tiziana Life Sciences' Foralumab Gains MyMatch Program Inclusion - GuruFocus

Nov 25, 2025

Nov 25, 2025

Tiziana Life Sciences’ Phase 2 foralumab trial joins Healey ALS MyMatch Program - Proactive financial news

Nov 25, 2025

Nov 25, 2025

Tiziana Life Sciences' Foralumab Phase 2 Trial for ALS Accepted into ALS MyMatch Program at Mass General Brigham - Quiver Quantitative

Nov 25, 2025

Nov 25, 2025

Tiziana Life Sciences Nasal Foralumab Phase 2 Clinical Trial Accepted into Healey ALS MyMatch Program - The Manila Times

Nov 25, 2025

Nov 25, 2025

TLSA ALS Phase 2 intranasal foralumab trial in ALS MyMatch - Stock Titan

Nov 25, 2025

Nov 25, 2025

Tiziana (Nasdaq: TLSA) Phase 2 nasal foralumab ALS trial joins Healey ALS MyMatch - Stock Titan

Nov 25, 2025

Nov 21, 2025

Will Tiziana Life Sciences Ltd stock benefit from sector rotation - newser.com

Nov 21, 2025

Nov 20, 2025

Will Tiziana Life Sciences Ltd stock reach all time highs in 20252025 Performance Recap & AI Driven Stock Reports - newser.com

Nov 20, 2025

Nov 20, 2025

Tiziana Life Sciences (NASDAQ:TLSA) Shares Down 4.5% – Here’s Why - Defense World

Nov 20, 2025

Nov 20, 2025

Will Tiziana Life Sciences Ltd stock outperform Nasdaq indexDollar Strength & Daily Profit Focused Screening - newser.com

Nov 20, 2025

Nov 19, 2025

3 Promising Penny Stocks With At Least $40M Market Cap - Yahoo Finance

Nov 19, 2025

Nov 19, 2025

Reversal indicators forming on Tiziana Life Sciences Ltd stockAnalyst Downgrade & High Yield Stock Recommendations - newser.com

Nov 19, 2025